Next Article in Journal
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Next Article in Special Issue
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
Previous Article in Journal
Selection of Suitable Reference Genes for Analysis of Salivary Transcriptome in Non-Syndromic Autistic Male Children
Previous Article in Special Issue
Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations
Due to scheduled maintenance work on our core network, there may be short service disruptions on this website between 16:00 and 16:30 CEST on September 25th.

The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity

Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, SE-17177 Stockholm, Sweden
Author to whom correspondence should be addressed.
Academic Editor: William Chi-shing Cho
Int. J. Mol. Sci. 2016, 17(10), 1714;
Received: 12 September 2016 / Revised: 23 September 2016 / Accepted: 27 September 2016 / Published: 12 October 2016
(This article belongs to the Special Issue Precision Medicine—From Bench to Bedside)
Responses to drugs and pharmacological treatments differ considerably between individuals. Importantly, only 50%–75% of patients have been shown to react adequately to pharmacological interventions, whereas the others experience either a lack of efficacy or suffer from adverse events. The liver is of central importance in the metabolism of most drugs. Because of this exposed status, hepatotoxicity is amongst the most common adverse drug reactions and hepatic liabilities are the most prevalent reason for the termination of development programs of novel drug candidates. In recent years, more and more factors were unveiled that shape hepatic drug responses and thus underlie the observed inter-individual variability. In this review, we provide a comprehensive overview of different principle mechanisms of drug hepatotoxicity and illustrate how patient-specific factors, such as genetic, physiological and environmental factors, can shape drug responses. Furthermore, we highlight other parameters, such as concomitantly prescribed medications or liver diseases and how they modulate drug toxicity, pharmacokinetics and dynamics. Finally, we discuss recent progress in the field of in vitro toxicity models and evaluate their utility in reflecting patient-specific factors to study inter-individual differences in drug response and toxicity, as this understanding is necessary to pave the way for a patient-adjusted medicine. View Full-Text
Keywords: drug-induced liver injury; hepatotoxicity; liver disease; pharmacogenetics drug-induced liver injury; hepatotoxicity; liver disease; pharmacogenetics
Show Figures

Figure 1

MDPI and ACS Style

Lauschke, V.M.; Ingelman-Sundberg, M. The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity. Int. J. Mol. Sci. 2016, 17, 1714.

AMA Style

Lauschke VM, Ingelman-Sundberg M. The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity. International Journal of Molecular Sciences. 2016; 17(10):1714.

Chicago/Turabian Style

Lauschke, Volker M., and Magnus Ingelman-Sundberg. 2016. "The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity" International Journal of Molecular Sciences 17, no. 10: 1714.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop